 MINNEAPOLIS, MN ACCESSWIRE April 26, 2021 Celcuity Inc. NASDAQ:CELC, a clinical-stage biotechnology company pursuing an integrated companion diagnostic CDx and therapeutic strategy for treating patients with cancer, today announced that it will release its financial results for the first quarter 2021 after the stock market close on Monday, May 10, 2021. Management will host a webcastconference call the same day at 4:30 p.m. 